½Û×ÓÊÓÆµ

Home / Simons-Taxes /Administration and compliance /Part A8 Coronavirus (COVID-19) /Division A8.1 Coronavirus (COVID-19) and business /Other impacts of coronavirus on businesses / A8.108 Research and development (R&D) claims and coronavirus (COVID-19)
Commentary

A8.108 Research and development (R&D) claims and coronavirus (COVID-19)

Administration and compliance

This content covers guidance applicable to the coronavirus (COVID-19) pandemic.

The CIOT received confirmation from HMRC on the following points in relation to the operation of the R&D regime and the processing of claims:

  1. Ìý

    •ÌýÌýÌýÌý processing of claims ― HMRC has confirmed that while the processing of claims will not be accelerated, it is still aiming to clear 95% of SME tax credit claims within 28 days, so claims for most companies should be processed within that time frame. However, this was subsequently changed to 85% of claims within 40 days (see CIRD80525)

  2. Ìý

    •ÌýÌýÌýÌý R&D repayments ― in terms of the research and development expenditure credit (RDEC), HMRC has confirmed that any

To continue reading
View the latest version of this document, as well as thousands of others like it, sign in to Tolley+™ Research or register for a free trial

Web page updated on 17 Mar 2025 17:26